估计肾小球滤过率和蛋白尿的时间更新变化与主要不良心脏事件:CRIC研究
本研究基于CRIC前瞻性队列2438名参与者,采用标志分析法评估时间更新的1年暴露窗口内eGFR和UPCR的平均值与斜率与3年心血管风险的关联。结果示更低的平均eGFR和下降斜率、更高的平均UPCR和上升斜率均独立与心衰和复合终点风险增加相关。短期肾功能变化提供超越肾功能水平的心血管风险信息。
要点
- eGFR均值每低1个标准差(19mL/min/1.73m2)与心衰风险增加相关(HR 1.82)。
- UPCR均值每高1个标准差(136mg/g)与心衰风险增加相关(HR 1.58)。
- eGFR和蛋白尿的短期变化可提供超越基线水平的心血管风险信息。
核心结论
- 在CRIC队列中,时间更新的eGFR和蛋白尿的平均值与斜率独立与3年心血管风险相关。
- 短期肾功能变化提供超越肾功能水平的心血管风险信息,可能为CKD患者管理提供机会。
研究设计与样本
- 前瞻性队列研究,纳入CRIC研究中2438名参与者,使用年度访视数据。
- 采用标志分析法评估时间更新的1年暴露窗口内eGFR和UPCR的平均值与斜率。
主要发现
- eGFR均值每低1个标准差(19mL/min/1.73m2),心衰风险HR为1.82(95% CI 1.39-2.44),复合终点HR为1.32(95% CI 1.11-1.54)。
- eGFR下降斜率每快1个标准差(8mL/min/1.73m2/年),心衰风险HR为1.28(95% CI 1.12-1.45),复合终点HR为1.11(95% CI 1.03-1.20)。
- UPCR均值每高1个标准差(136mg/g),心衰风险HR为1.58(95% CI 1.28-1.97),复合终点HR为1.33(95% CI 1.17-1.50)。
- UPCR上升斜率每快1个标准差(240mg/g/年),心衰风险HR为1.20(95% CI 1.10-1.29),复合终点HR为1.12(95% CI 1.06-1.18)。
临床怎么用
- 在CKD患者中,定期监测eGFR和蛋白尿的动态变化有助于评估短期心血管风险。
- eGFR下降或蛋白尿上升的短期趋势应引起临床关注,可能提示需要更积极的心血管风险管理。
局限性
- 年度eGFR和UPCR评估的普遍性有限。
- 若干心血管疾病风险生物标志物未每年获取。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Evaluating repeated measures of estimated glomerular filtration rate (eGFR) and urinary protein-creatinine ratio (UPCR) over time may enhance our ability to understand the association between changes in kidney parameters and cardiovascular disease risk. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Annual visit data from 2,438 participants in the Chronic Renal Insufficiency Cohort (CRIC). EXPOSURES: Average and slope of eGFR and UPCR in time-updated, 1-year exposure windows. OUTCOMES: Incident heart failure, atherosclerotic cardiovascular disease events, death, and a composite of incident heart failure, atherosclerotic cardiovascular disease events, and death. ANALYTICAL APPROACH: A landmark analysis, a dynamic approach to survival modeling that leverages longitudinal, iterative profiles of laboratory and clinical information to assess the time-updated 3-year risk of adverse cardiovascular outcomes. RESULTS: Adjusting for baseline and time-updated covariates, every standard deviation lower mean eGFR (19mL/min/1.73m2) and declining slope of eGFR (8mL/min/1.73m2 per year) were independently associated with higher risks of heart failure (hazard ratios [HRs] of 1.82 [95% CI, 1.39-2.44] and 1.28 [95% CI, 1.12-1.45], respectively) and the composite outcome (HRs of 1.32 [95% CI, 1.11-1.54] and 1.11 [95% CI, 1.03-1.20], respectively). Every standard deviation higher mean UPCR (136mg/g) and increasing UPCR (240mg/g per year) were also independently associated with higher risks of heart failure (HRs of 1.58 [95% CI, 1.28-1.97] and 1.20 [95% CI, 1.10-1.29], respectively) and the composite outcome (HRs of 1.33 [95% CI, 1.17-1.50] and 1.12 [95% CI, 1.06-1.18], respectively). LIMITATIONS: Limited generalizability of annual eGFR and UPCR assessments; several biomarkers for cardiovascular disease risk were not available annually. CONCLUSIONS: Using the landmark approach to account for time-updated patterns of kidney function, average and slope of eGFR and proteinuria were independently associated with 3-year cardiovascular risk. Short-term changes in kidney function provide information about cardiovascular risk incremental to level of kidney function, representing possible opportunities for more effective management of patients with chronic kidney disease.
引用
- Cohen JB, Yang W, Li L, et al. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021. PMID: 34052355. doi:10.1053/j.ajkd.2021.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。